The spike-in of synthetic hsa-lest-7a-5p miRNA decreases the Ct Values of extracted small RNA samples. by Marc Van Der Hofstadt (1423027)

Distribution of KTAS levels and outcomes in the study population by age. by Hun Gi Lee (21526538)

Subjects:

Demographic characteristics of the study population. by Hun Gi Lee (21526538)

Subjects:

Emergency department dispositions of the study population. by Hun Gi Lee (21526538)

Subjects:

Univariate and multivariate logistic regression analyses of the impact of Safe-Speed-5030 on the study population. by Hun Gi Lee (21526538)

Subjects:

Clinical characteristics of the study population. by Hun Gi Lee (21526538)

Subjects:

Fig 1 - by Farshid Maleki (20521649)

Subjects:

Fig 5 - by Farshid Maleki (20521649)

Subjects:

Rate of apoptosis in MDA-MB-231 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C). by Farshid Maleki (20521649)

Subjects:

Fig 10 - by Farshid Maleki (20521649)

Subjects:

Rate of apoptosis in MCF-7 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C). by Farshid Maleki (20521649)

Subjects:

<b> </b> Rate of brain weight to body weight in different experimental groups. AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate.... by Atefeh Sadeghi (21253051)

“…AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate. …”

Fig 4 - by Farshid Maleki (20521649)

Subjects:

Fig 9 - by Farshid Maleki (20521649)

Subjects:

Fig 6 - by Farshid Maleki (20521649)

Subjects:

Fig 7 - by Farshid Maleki (20521649)

Subjects:

Fig 8 - by Farshid Maleki (20521649)

Subjects:

Quantification of bacterial adhesion revealed a significant decrease in the adhesion of <i>S. aureus</i>, <i>S. epidermidis</i>, and <i>P. aeruginosa</i> on blotted corneas of mice treated with 0.5% bupivacaine (BUP) combined with topical (TOP) application, following subconjunctival injection (SCI) of CGRP, 24 hours before the final BUP treatment (day 14) and again one hour prior to the final bupivacaine injection on day 15. by Ananya Datta (19932144)

Mean age of patients submitting stool samples per study site. by Amete Mihret Teshale (12072758)

Subjects:

Forest plot showing the mean difference of global IQ level among pediatric brain cancer patients treated with either PT or XRT. by Renáta Kiss-Miki (20760127)

Subjects: